APA (7th ed.) Citation

Esquer, H., Zhou, Q., & LaBarbera, D. V. Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer. MDPI AG.

Chicago Style (17th ed.) Citation

Esquer, Hector, Qiong Zhou, and Daniel V. LaBarbera. Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer. MDPI AG.

MLA (9th ed.) Citation

Esquer, Hector, et al. Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer. MDPI AG.